(Q33863392)

29 July 2017

1 reference

title

Advances in non-nicotine pharmacotherapy for smoking cessation (English)

1 reference

29 July 2017

0 references

0 references

Covey LS

1

1 reference

29 July 2017

Sullivan MA

2

1 reference

29 July 2017

Johnston JA

3

1 reference

29 July 2017

Glassman AH

4

1 reference

29 July 2017

Robinson MD

5

1 reference

29 July 2017

Adams DP

6

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

59

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

17-31

1 reference

Naltrexone in the treatment of alcohol dependence

29 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059010-00003

Pharmacological and psychological determinants of smoking. A New York University honors program lecture

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059010-00003

One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059010-00003

Is clonidine an effective smoking cessation therapy?

21 January 2018

1 reference

12 December 2020

Can buspirone induce rebound, dependence or abuse?

1 reference

12 December 2020

Clinical evaluation of mecamylamine for withdrawal from nicotine dependence

1 reference

12 December 2020

Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking

1 reference

12 December 2020

Methods of smoking cessation

1 reference

12 December 2020

Efficacy of buspirone in smoking cessation: a placebo-controlled trial

1 reference

12 December 2020

Serotonin receptor specificity in anxiety disorders

1 reference

12 December 2020

Effect of glucose tablets on craving for cigarettes

1 reference

12 December 2020

Tobacco cessation interventions in health care settings: rationale, model, outcomes

1 reference

12 December 2020

A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers.

1 reference

12 December 2020

Airway sensory replacement combined with nicotine replacement for smoking cessation. A randomized, placebo-controlled trial using a citric acid inhaler

1 reference

12 December 2020

Low platelet monoamine oxidase activity in cigarette smokers

1 reference

12 December 2020

The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity.

1 reference

12 December 2020

Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers

1 reference

12 December 2020

Naloxone does not affect cigarette smoking

1 reference

12 December 2020

A critical review and evaluation of smoking control methods

1 reference

12 December 2020

Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers

1 reference

12 December 2020

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

12 December 2020

Cigarette craving, smoking withdrawal, and clonidine.

1 reference

12 December 2020

Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine

1 reference

12 December 2020

Sensitization of the mesoaccumbens dopamine response to nicotine.

1 reference

12 December 2020

Naltrexone effects on short-term and long-term smoking cessation

1 reference

12 December 2020

Nicotine medications for smoking cessation

1 reference

12 December 2020

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

1 reference

12 December 2020

Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers.

1 reference

12 December 2020

Effect of Buspirone on Withdrawal Symptoms Associated With Smoking Cessation

1 reference

12 December 2020

Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms.

1 reference

12 December 2020

Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic

1 reference

12 December 2020

A population-based twin study in women of smoking initiation and nicotine dependence

1 reference

12 December 2020

A randomized trial of naltrexone for smoking cessation.

1 reference

12 December 2020

Buspirone effect on tobacco withdrawal symptoms: a randomized placebo-controlled trial

1 reference

12 December 2020

Lobeline and Reduction of Cigarette Smoking

1 reference

12 December 2020

Relapse prevention strategies for the treatment of cocaine abuse

1 reference

12 December 2020

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

12 December 2020

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

1 reference

12 December 2020

Risk rates for depression

1 reference

12 December 2020

A randomized trial of nortriptyline for smoking cessation

1 reference

12 December 2020

Smoking, smoking cessation, and major depression

1 reference

12 December 2020

Naltrexone, smoking behaviour and cigarette withdrawal.

1 reference

12 December 2020

Buspirone reduces smoking

1 reference

12 December 2020

Depression and depressive symptoms in smoking cessation

1 reference

12 December 2020

Nicotine dependence--mechanisms and therapeutic strategies

1 reference

12 December 2020

Withdrawal from nicotine dependence using mecamylamine: comparison of three-week and six-week dosage schedules

1 reference

12 December 2020

Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial

1 reference

12 December 2020

Double-blind placebo controlled trial of dextrose tablets and nicotine patch in smoking cessation

1 reference

12 December 2020

A meta-analysis of double-blind placebo-controlled trials of clonidine for smoking cessation

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs

1 reference

12 December 2020

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

1 reference

12 December 2020

Recent advances in the pharmacotherapy of smoking

1 reference

12 December 2020

1 reference

12 December 2020

Methods used to quit smoking in the United States. Do cessation programs help?

1 reference

12 December 2020

Influencing cigarette smoking with nicotine antagonists

1 reference

12 December 2020

Inhibition of monoamine oxidase B in the brains of smokers

1 reference

12 December 2020

Doxepin as an adjunct to smoking cessation: a double-blind pilot study

1 reference

12 December 2020

Mecamylamine increases nicotine preference and attenuates nicotine discrimination

1 reference

12 December 2020

The functional role of monoamine oxidases A and B in the mammalian central nervous system.

1 reference

12 December 2020

Role of nicotine dose and sensory cues in the regulation of smoke intake

1 reference

12 December 2020

Naloxone reduces cigarette smoking

1 reference

12 December 2020

10.2165/00003495-200059010-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1000136869

0 references

1 reference